Jane Street’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,895
Closed -$1.3M 12556
2025
Q4
$1.3M Sell
7,895
-10,247
-56% -$1.36M ﹤0.01% 5606
2025
Q3
$1.87M Buy
+18,142
New +$1.78M ﹤0.01% 5060
2025
Q2
Sell
-11,100
Closed -$522K 10478
2025
Q1
$522K Buy
+11,100
New +$542K ﹤0.01% 6777
2024
Q2
Sell
-143
Closed -$2.06K 9939
2024
Q1
$2.06K Buy
+143
New +$2.88K ﹤0.01% 9063
2023
Q3
Sell
-2,239
Closed -$142K 9142
2023
Q2
$142K Buy
+2,239
New +$192K ﹤0.01% 7840
2023
Q1
Sell
-151
Closed -$43K 9649
2022
Q4
$43K Buy
+151
New +$29K ﹤0.01% 8412

Other funds holding NUTX

Jane Street's NUTX Position: Q1 2026 in Review

Jane Street sold out of Nutex Health (NUTX) in Q1 2026, closing a stake of 7,895 shares — an estimated $1.3M sold.

Jane Street first reported a position in NUTX in Q4 2022 and held it in 6 quarters. The position peaked at $1.87M in Q3 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Jane Street reported no remaining Nutex Health position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 7,895 Nutex Health shares in Q1 2026, an estimated $1.3M.
  • Jane Street first reported a position in Nutex Health in Q4 2022 and held it in 6 quarters.
  • Jane Street's Nutex Health position peaked at $1.87M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.